- Motley Fool•36 minutes ago
The latest innovation in blood thinners could make investors heart-stopping profits.
- The Wall Street Journal•2 hours ago
The same day Bristol-Myers Squibb Co. shook up its board to satisfy one activist investor, the drugmaker was faced with another: Carl Icahn, whose interest is fueling speculation the company could soon ...
BMY : Summary for Bristol-Myers Squibb Company Co - Yahoo Finance
Bristol-Myers Squibb Company (BMY)
NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
|Day's Range||53.41 - 57.21|
|52 Week Range||46.01 - 77.12|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||20.67|
|Dividend & Yield||1.56 (2.86%)|
|1y Target Est||N/A|